SPARSENTAN (SPAR) AS FIRST-LINE TREATMENT OF INCIDENT PATIENTS WITH IgA NEPHROPATHY (IgAN): INTERIM ANALYSIS OF THE SPARTAN TRIAL

SPARSENTAN (SPAR) AS FIRST-LINE TREATMENT OF INCIDENT PATIENTS WITH IgA NEPHROPATHY (IgAN): INTERIM ANALYSIS OF THE SPARTAN TRIAL
E-Poster Presentation

During the congress, E-Posters will be accessible to all participants on the congress website 24/7, as well as in the E-poster stations in the congress center. 

Preparing your E-Poster

Please review the E-Poster format requirements carefully when preparing your E-Poster. Should your E-Poster not meet the mentioned requirements, it may not be displayed as described above.

​E-Poster Submission Deadline

Please prepare and upload your E-Poster no later than January 23, 2025. After this date, you will no longer be able to prepare and upload your E-poster and it will not be displayed and accessible on the congress website.​

E-Poster Format Requirements
  • PDF file
  • Layout: Portrait (vertical orientation)
  • One page only (Dim A4: 210 x 297mm or PPT)
  • E-Poster can be prepared in PowerPoint (one (1) PowerPoint slide) but must be saved and submitted as PDF file.
  • File Size: Maximum file size is 2 Megabytes (2 MB)
  • No hyperlinks, animated images, animations, and slide transitions
  • Language: English
  • Include your abstract number
  • E-posters can include QR codes, tables and photos
https://storage.unitedwebnetwork.com/files/1099/f51a72af15f4db03ee513fb395b2e213.pdf
Alex
Mercer
10
Radko Komers radko.komers@travere.com Travere Therapeutics, Inc. Clinical Development, Nephrology San Diego United States
Chee Kay Cheung cheekay.cheung@uhl-tr.nhs.uk University of Leicester & Leicester General Hospital N/A Leicester United Kingdom
Stephanie Moody stephanie.moody@travere.com Travere Therapeutics, Inc. Biostatistics San Diego United States
Neeraj Dhaun bean.dhaun@ed.ac.uk Department of Renal Medicine, Royal Infirmary of Edinburgh Department of Renal Medicine Edinburgh United Kingdom
Siân Griffin sian.griffin2@wales.nhs.uk University Hospital of Wales Department of Nephrology and Transplantation Cardiff United Kingdom
Alexandra Howson alexandra.l.howson@uhl-tr.nhs.uk University of Leicester & Leicester General Hospital N/A Leicester United Kingdom
Alex Mercer alex.mercer@travere.com JAMCO Pharma Consulting N/A Stockholm Sweden
Matthew Sayer msayer2@exseed.ed.ac.uk Royal Infirmary of Edinburgh Department of Renal Medicine Edinburgh United Kingdom
Smeeta Sinha smeeta.sinha@nca.nhs.uk Department of Renal Medicine Salford Royal Hospital, Northern Care Alliance NHS Foundation Trust Salford United Kingdom
Lisa Willcocks lisa.willcocks@nhs.net Department of Renal Medicine Addenbrooke's Hospital, Cambridge University Hospitals Cambridge United Kingdom
Jonathan Barratt jb81@le.ac.uk University of Leicester & Leicester General Hospital Department of Nephrology Leicester United Kingdom